Overview
ASTM F3212-16(2023), Standard Test Method for Coring Testing of Huber Needles, establishes a consistent and qualitative method for evaluating the potential of Huber-type needles to remove (core) septum material when accessing implantable ports. This international standard, developed by ASTM International, is designed to ensure Huber needles are manufactured to a standard that reduces the risk of producing septum cores, which can compromise device integrity and patient safety. Coring, if it occurs, may lead to leakage in the implantable port or migration of septum fragments into the patient's system.
Key Topics
- Huber Needle Coring: Focuses on whether Huber needles remove septum material during simulated access of implantable ports, assessing their design as non-coring needles.
- Qualitative Assessment: The test method is primarily a pass/fail evaluation based on the presence or absence of a core in the needle's cannula after perforation of a septum surrogate.
- Test Apparatus and Procedure:
- Utilizes a clamping fixture to securely hold a molded silicone septum disk.
- Requires observation of the needle's lumen with an optical microscope after simulated access.
- Incorporates additional tools like stylets to confirm the presence or absence of septum cores.
- Limitations: The standard does not address quantitative force measurements, septum durability, or broader safety concerns. It is the user’s responsibility to implement safe practices and compliance with applicable regulations.
Applications
This coring testing method is vital in the following contexts:
- Medical Device Evaluation: Used by manufacturers to ensure Huber needles meet non-coring requirements before being distributed for clinical use.
- Design Verification: Integral for research and development teams to validate the design of new or improved Huber-type needle models.
- Quality Assurance: Applied during production to maintain high standards of device safety and usability, supporting consistent quality in batch manufacturing.
- Regulatory Compliance: Assists in documentation and compliance with international quality and safety management frameworks for medical devices, particularly for products intended for use with implantable ports.
- Clinical Risk Reduction: Reduces the risk of leaked medications and foreign body embolization by ensuring port access devices do not cause coring, safeguarding patient health.
Related Standards
To enhance quality control and harmonize testing protocols, users of ASTM F3212-16(2023) should consider the following related standards:
- ASTM D2240: Standard Test Method for Rubber Property-Durometer Hardness, which is referenced for the characterization of the silicone septum material’s hardness.
- ISO 8536 Series: Standards for infusion equipment and needles, offering additional guidance on safety and performance.
- FDA Quality System Regulation (21 CFR Part 820): U.S. requirements for medical device manufacturers regarding risk management and product safety.
- Other ASTM Medical Device Standards: Especially those developed under the ASTM Committee F04 on Medical and Surgical Materials and Devices.
Practical Value
Implementing ASTM F3212-16(2023) ensures:
- Increased Patient Safety: Minimizes risks of port leakage and embolism.
- Standardized Manufacturing: Facilitates reproducible and reliable production of non-coring Huber needles.
- Regulatory Readiness: Supports compliance for market access in regions upholding international standards.
By integrating this standard into product development and quality assurance procedures, medical device manufacturers uphold the highest standards for injectable device safety and clinical performance.